Related Experiment Videos
Type 2 diabetes mellitus: the grand overview
1Medlantic Research Institute, Washington, DC, USA.
Diabetic Medicine : a Journal of the British Diabetic Association
|December 30, 1998
Summary
Early detection and intervention are key to preventing Type 2 diabetes and its complications. Large-scale studies like STOP NIDDM and DPP are evaluating strategies to combat this growing epidemic.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Transplantation Immunology
Background:
- Type 2 diabetes represents a significant financial burden on healthcare systems, costing over $100 billion annually in the US.
- A substantial proportion of hospital beds and cardiac care patients are occupied by individuals with diabetes, highlighting its systemic impact.
- Despite intensive therapy, early complications like retinopathy and peripheral vascular disease are prevalent even at diagnosis.
Purpose of the Study:
- To explore the potential of early carbohydrate intolerance detection for preventing Type 2 diabetes onset and progression.
- To review ongoing intervention trials aimed at preventing Type 2 diabetes and associated cardiovascular risks.
- To assess the current status and future potential of pancreas and islet-cell transplantation for managing Type 2 diabetes.
Main Methods:
- Review of computer modeling and clinical trial data on intensive diabetes therapy.
- Analysis of large-scale prevention trials: Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP NIDDM) and Diabetes Prevention Program (DPP).
- Evaluation of outcomes from pancreas and islet-cell transplantation in Type 2 diabetic patients.
Main Results:
- Intensive diabetes therapy shows promise in reducing morbidity and healthcare costs.
- Ongoing trials (STOP NIDDM, DPP) are investigating the efficacy of lifestyle and pharmacological interventions in individuals with impaired glucose tolerance.
- Pancreas and islet-cell transplantation offer potential 'cure' for Type 2 diabetes, with promising outcomes, especially islet-cell transplants.
Conclusions:
- Early identification of high-risk individuals and proactive interventions are crucial for stemming the Type 2 diabetes epidemic.
- Large-scale prevention programs are essential for developing public health models to combat diabetes.
- Transplantation technologies, particularly islet-cell transplantation, represent a significant future hope for Type 2 diabetes management.